Get the Stockscreener App
35.01
0.46%
0.16
After Hours:
35.01
Surmodics Inc stock is traded at $35.01, with a volume of 85,169.
It is up +0.46% in the last 24 hours and down -8.23% over the past month.
See More
Previous Close:
$34.85
Open:
$34.89
24h Volume:
85,169
Relative Volume:
0.68
Market Cap:
$549.47M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
92.13
EPS:
0.38
Net Cash Flow:
$9.86M
1W Performance:
+2.67%
1M Performance:
-8.23%
6M Performance:
-11.84%
1Y Performance:
+6.77%
1-Day Range:
$34.76
$35.15
1-Week Range:
$33.98
$35.15
52-Week Range:
$25.17
$42.44
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Compare SRDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
35.01 | 549.47M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-13-23 | Upgrade | Needham | Hold → Buy |
| Feb-13-23 | Downgrade | Needham | Buy → Hold |
| Jul-23-20 | Upgrade | Needham | Hold → Buy |
| Dec-11-19 | Downgrade | Needham | Buy → Hold |
| Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Lake Street | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Feb-21-19 | Reiterated | Needham | Buy |
| May-16-18 | Reiterated | Needham | Buy |
| Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-18 | Reiterated | Lake Street | Buy |
| Feb-28-18 | Initiated | Needham | Buy |
| Jul-14-17 | Initiated | Lake Street | Buy |
| Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
| May-03-16 | Reiterated | Barrington Research | Outperform |
| Aug-06-15 | Reiterated | Barrington Research | Outperform |
| Mar-27-15 | Initiated | Dougherty & Company | Buy |
| Feb-25-14 | Initiated | Laidlaw | Buy |
| Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
| Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
What is Zacks Research’s Estimate for Surmodics Q2 Earnings? - Defense World
Q3 Earnings Forecast for Surmodics Issued By Zacks Research - Defense World
Surmodics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
(SRDX) Technical Data - Stock Traders Daily
Surmodics shareholders approve key proposals at annual meeting - MSN
Surmodics shareholders approve key proposals at annual meeting By Investing.com - Investing.com Nigeria
Surmodics (NASDAQ:SRDX) Issues Quarterly Earnings Results - Armenian Reporter
Surmodics Q2 EPS Estimate Decreased by Barrington Research - MarketBeat
Top 3 Health Care Stocks You'll Regret Missing This Month - Benzinga
Short Interest in Surmodics, Inc. (NASDAQ:SRDX) Increases By 33.0% - MarketBeat
Ratios in Focus: Analyzing Surmodics, Inc (SRDX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Surmodics' (SRDX) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Surmodics (NASDAQ:SRDX) Posts Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
What is Zacks Research's Estimate for Surmodics Q2 Earnings? - MarketBeat
SurModics (SRDX) Loses -13.87% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Revolutionary Blood Clot Treatment: Surmodics' New Pounce XL System Tackles Larger Arteries - StockTitan
Surmodics (NASDAQ:SRDX) Now Covered by StockNews.com - Defense World
Barrington Research Lowers Earnings Estimates for Surmodics - Defense World
Surmodics (SRDX) Expected to Announce Earnings on Thursday - MarketBeat
Surmodics (NASDAQ:SRDX) Trading Down 5.5%Time to Sell? - MarketBeat
Zacks Research Has Positive Outlook of Surmodics Q2 Earnings - Defense World
Surmodics Stock Down Despite Q1 Earnings Beat, Gross Margin Up - MSN
Zacks Research Increases Earnings Estimates for Surmodics - Defense World
SurModics: Fiscal Q1 Earnings Snapshot - CT Insider
Surmodics Reports Q1 Loss and Strategic Moves - TipRanks
SurModics (SRDX) Reports Q1 Loss, Misses Revenue Estimates - MSN
Compared to Estimates, SurModics (SRDX) Q1 Earnings: A Look at Key Metrics - Nasdaq
Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results - BioSpace
Surmodics Earnings Analysis: Q1 Recap - Benzinga
Surmodics Inc. (SRDX) reports earnings - Quartz
Surmodics Inc Reports Q1 FY2025 EPS of $(0.26) and Revenue of $2 - GuruFocus.com
SurModics: Fiscal Q1 Earnings Snapshot -January 30, 2025 at 07:25 am EST - Marketscreener.com
Surmodics (SRDX) to Release Earnings on Thursday - Defense World
Here's Why You Should Add Surmodics Stock to Your Portfolio Now - MSN
Surmodics falls on report about FTC review of GTCR deal - Seeking Alpha
Surmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.com - Defense World
JPMorgan Chase & Co. Buys 27,960 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):